Characterizing aggressiveness and predicting future progression of CF lung disease.
about
Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal studyAssociation between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosisPulmonary outcome prediction (POP) tools for cystic fibrosis patients.The relationship of systemic inflammation to prior hospitalization in adult patients with cystic fibrosis.Decade-long bacterial community dynamics in cystic fibrosis airways.Improvements in lung function and height among cohorts of 6-year-olds with cystic fibrosis from 1994 to 2012.Cholesteryl esters are elevated in the lipid fraction of bronchoalveolar lavage fluid collected from pediatric cystic fibrosis patients.Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease.The Dynamics of Disease Progression in Cystic Fibrosis.Modeling the impact of antibiotic exposure on human microbiota.IL8 gene as modifier of cystic fibrosis: unraveling the factors which influence clinical variability.Effect of dornase alfa on inflammation and lung function: potential role in the early treatment of cystic fibrosis.Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.
P2860
Q28388812-2422E6BC-59CD-4B40-B3D3-D6A7EF863A80Q33810871-E7201F39-9C28-454B-9D6B-FED590603FADQ33957181-F164E8EC-BBB2-42DB-8449-E0C969473EF7Q34158550-4AD18EF2-A4C5-44EC-A821-8A06A746882AQ34209009-1C9B46E2-DD02-4E7C-A8FF-0C945D33FD97Q34615096-B624B20C-6078-4E09-9BF8-6690F34FCD17Q35546970-B24DFA45-268F-4FDA-886B-5015CE013F5EQ35801062-770FC71C-17B0-4466-9E58-EF92D422D076Q36036190-D01B2D96-B871-4258-91B3-4D4547F74C73Q37629657-076EDCBD-02D2-4438-BE54-98EF3FCC1427Q40664954-8B5C2ACF-B9CF-46A6-8808-353F02244BC8Q42728646-42B7A5BF-DB0A-467E-8AAF-DB9D0CB58357Q55287506-9598801C-E8B4-4D7C-80F8-C25277914469
P2860
Characterizing aggressiveness and predicting future progression of CF lung disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Characterizing aggressiveness and predicting future progression of CF lung disease.
@ast
Characterizing aggressiveness and predicting future progression of CF lung disease.
@en
Characterizing aggressiveness and predicting future progression of CF lung disease.
@nl
type
label
Characterizing aggressiveness and predicting future progression of CF lung disease.
@ast
Characterizing aggressiveness and predicting future progression of CF lung disease.
@en
Characterizing aggressiveness and predicting future progression of CF lung disease.
@nl
prefLabel
Characterizing aggressiveness and predicting future progression of CF lung disease.
@ast
Characterizing aggressiveness and predicting future progression of CF lung disease.
@en
Characterizing aggressiveness and predicting future progression of CF lung disease.
@nl
P2093
P2860
P1476
Characterizing aggressiveness and predicting future progression of CF lung disease.
@en
P2093
Donald R VanDevanter
Jeffrey S Wagener
Michael W Konstan
P2860
P356
10.1016/S1569-1993(09)60006-0
P478
P577
2009-06-01T00:00:00Z